Atheln helps clients create and execute integrated pharma and biotech product development and commercialization strategies.
Our global team of over 100 highly specialized, industry-seasoned experts excel at risk identification and mitigation, while delivering phase appropriate and customized solutions that maximize value and increase the likelihood of success for our clients.
Meet our ophthalmic product development experts in Booth 1157.
Contact adriana@athelnbiomed.com to set up
a meeting.
Our dedicated and highly specialized experts (each with 20–40 years of experience) have been key contributors in the development of numerous marketed ophthalmic products.
23 companies have collaborated with Atheln on 32 projects for most ophthalmic indications. Our support has spanned from due diligence and preparing for Pre-IND meetings to complete development programs reaching NDA filing.
Atheln supports clients with strategies and implementation of plans for:
- Chemistry, Manufacturing and Controls
- Clinical, Non-clinical and Regulatory
- Management of CMOs/CRO
Across a wide variety of technologies
- All API modalities (small molecules, peptides, mAbs, fusion proteins, cell and gene therapies, etc.)
- Formulation types and delivery modalities (solutions, suspensions, gels, sustained release, etc.)
- Routes of administration (topical, intracameral/ intravitreal injectables, subconjunctival, etc.)
- Device-drug combination products (non-eroding and biodegradable implants, IOLs, etc.)
And experience with most anterior and posterior ocular diseases.
Core Competencies